Emmecell has published positive topline outcomes from a Phase I trial of EO2002, its nonsurgical cell therapy candidate for ...

The study confirmed that Afqlir has equivalent efficacy and comparable safety to its reference medicine, Eylea.

Brain oedema after major ischaemic infarction is a life-threatening complication for which no preventive therapy exists. Decompressive hemicraniectomy can be lifesaving and improve functional outcomes ...

Alzheimer's wonder drugs aren't yet delivering on their promise. American researchers have come up with a brand new idea, a ...

Following US approval in May this year, South Korea’s Samsung Bioepis and US biotech Biogen have now won approval from the ...

(RTTNews) - Samsung Bioepis Co., Ltd. and Biogen Inc. (BIIB) Monday announced that the European Commission (EC) has approved Opuviz, a biosimilar to Regeneron Pharmaceuticals' Aflibercept.

OPUVIZ™ is one of the first wave aflibercept biosimilars in EuropeOPUVIZ is the second European Commission (EC)-approved ophthalmology biosimilar under Samsung Bioepis and Biogen’s partnershipEC ...

SAN FRANCISCO and KIGALI, Rwanda, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bio Usawa and the Rwanda Development Board have partnered to establish Rwanda’s first manufacturing plant for affordable treatments ...

The aftermath was horrific — thousands died due to asphyxiation and oedema in the lungs and many more thousands suffered ...

Pakistani high-altitude porters remain invisible. Expedition companies mostly hire Nepalese sherpas, even for the mountains ...

Wounds take time to heal but in older adults the time taken may be longer An expert explains why and steps one can take to speed up recovery ...

A CONDITION that affects over a million people in the UK can turn life-threatening during cold weather. But many Brits have ...